Herrera-Hernández, C.; Segura-Diaz, A.; Stuckey, R.; López-RodrÃguez, J.F.; Gómez-Casares, M.T.
Tyrosine Kinase Inhibitor Treatment of a Patient with Chronic Myeloid Leukemia and Congenital Thrombophilia. Hematol. Rep. 2025, 17, 47.
https://doi.org/10.3390/hematolrep17050047
AMA Style
Herrera-Hernández C, Segura-Diaz A, Stuckey R, López-RodrÃguez JF, Gómez-Casares MT.
Tyrosine Kinase Inhibitor Treatment of a Patient with Chronic Myeloid Leukemia and Congenital Thrombophilia. Hematology Reports. 2025; 17(5):47.
https://doi.org/10.3390/hematolrep17050047
Chicago/Turabian Style
Herrera-Hernández, Carol, Adrián Segura-Diaz, Ruth Stuckey, Juan Francisco López-RodrÃguez, and MarÃa Teresa Gómez-Casares.
2025. "Tyrosine Kinase Inhibitor Treatment of a Patient with Chronic Myeloid Leukemia and Congenital Thrombophilia" Hematology Reports 17, no. 5: 47.
https://doi.org/10.3390/hematolrep17050047
APA Style
Herrera-Hernández, C., Segura-Diaz, A., Stuckey, R., López-RodrÃguez, J. F., & Gómez-Casares, M. T.
(2025). Tyrosine Kinase Inhibitor Treatment of a Patient with Chronic Myeloid Leukemia and Congenital Thrombophilia. Hematology Reports, 17(5), 47.
https://doi.org/10.3390/hematolrep17050047